Illustrative composite case study. Details are representative of the engagements Ansible undertakes and do not identify a specific client.
The paradox of the national champion
China has produced a generation of world-class fintech companies — in payments, digital lending, wealthtech, and insurtech — that dominate one of the most demanding markets on earth. Yet dominance at home does not translate automatically into growth abroad. For many Chinese fintechs, going global turns out to be a harder problem than the one they have already solved.
Why expansion is harder for Chinese companies
The barriers are rarely about the product. They are commercial, regulatory, and relational:
- Market access and licensing. Financial services are among the most heavily licensed industries in every market. A payments or lending licence in Indonesia, Vietnam, or Thailand can take many months and demands a local entity, local capital, and often a local partner.
- Capital that does not yet know you. Regional investors and strategic partners may admire Chinese innovation but lack an established relationship of trust. Raising growth capital in a new market is as much about credibility as numbers.
- Trust and localization. Distributors, regulators, and enterprise customers work with partners they know. An outbound entrant has to build that trust from zero — in a new language and under unfamiliar norms.
- Data, compliance, and cross-border friction. Data-residency rules, KYC and AML regimes, and shifting market-access conditions add cost and delay that local incumbents never face.
None of this is about politics. It is the ordinary friction of being new, foreign, and far from the decision-makers — friction that is simply higher for companies expanding out of China than for a local or Western incumbent.
Reading the map before moving
Before committing capital, the smartest expanders study where trade and demand actually flow. Harvard’s Growth Lab publishes the Atlas of Economic Complexity, an interactive trade map covering roughly 250 countries and some 6,000 products and services. Its markets view shows which economies are absorbing which goods and services, and how those flows are shifting over time.
For a Chinese fintech, the Atlas is a way to pressure-test intuition with data: which Southeast Asian markets are deepening their trade and digital ties with China, where complementary industries are growing, and which corridors are widening rather than narrowing. Market selection stops being a guess and becomes a reading of the map.
The engagement
A Chinese payments-and-wealthtech company — profitable at home and valued in the billions — wanted a Southeast Asian foothold within a year. Two earlier attempts had stalled: a licence application that lapsed, and a distribution deal that never closed.
Working as an operating partner rather than an adviser, Ansible:
- Selected the market using trade-flow and demand data alongside on-the-ground diligence, narrowing eight candidates to one high-fit entry market.
- Structured a compliant path — a local entity, a licensing route mapped with regulatory counsel, and a joint venture with a trusted local operator.
- Introduced aligned capital — regional investors who understood the business and could open doors, not merely write cheques.
- Executed on the ground — from first local hire to launch, staying in-market until the product was live and compliant.
The outcome
The company launched in its first Southeast Asian market in under six months — licensed and operating, with a local partner and a capital base already in place for the next country. What had stalled twice moved once the barriers were owned by a partner with skin in the game.
The lesson
For Chinese fintechs, the hard part of globalization is not the technology — it is the licences, the partners, the capital relationships, and the trust that must be built market by market. Those barriers are real, and they are higher for outbound Chinese companies than for almost anyone else. That is precisely why an operating partner who co-owns the outcome changes the odds.